Featured Speakers

• 

  John LambertEVP & CSO ImmunoGen

• 

  Manish GuptaAssociate Director, Clinical Pharmacology & Pharmacometrics Bristol-Myers Squibb

• 

  Antonio GualbertoGroup Head, Clinical Research Millennium

• 

  David SatijnAssociate Director Genmab

• 

  Mike SunAssociate Director Seattle Genetics

• 

  Puja SapraDirector Pfizer

• 

  Leonard ReynoSenior Vice President & CMO Agensys

• 

  Ulrich BrinkmannScientific Director Roche

Join the industry leaders at Europe’s leading ADC Summit

Antibody drug conjugate experts are descending on Frankfurt in February as the European community convenes for its annual Summit. This year at the top of the agenda are issues surrounding European regulation, ADC characterisation & process development and drug safety & PK.

Through dedicated networking sessions and informative presentations, stakeholders new and old will refine how they can develop and implement a successful ADC program.

“The ADC Summit is very informative for people who are new to this field as well as the ADC experts. All of the talks were excellent”. Bristol-Myers Squibb

Working with pioneers at the likes of Pfizer, Roche, Takeda, Seattle Genetics, ImmunoGen, Astellas, Novartis, Millennium & Genmab to build the agenda, this year’s World ADC Summit will:

• Detail the latest innovations in linker design and conjugation methods
• Help improve your understanding of the intricacies of ADC pharmacokinetics with emphasis on the roles of payload, linker and mAb
• Provide you with clinical perspectives from the most exciting programmes: Adcetris, T-DM1, SAR3419, CMC-544, BT-062 and AGS-16M8F
• Highlight progress in proof of efficacy against novel ADC targets such as tissue factor, PSMA and CD138.
• Enable you to develop effective ADC manufacturing processes and successfully characterisation your drug 
• Give you an unparalleled opportunity to meet and network with Europe’s leading players…

Download the brochure for more detail on all of these topics and make sure you check out the interactive pre-conference workshops on ADC pharmacokinetics, manufacturing and regulation. 

What’s next?

1. Download the brochure to see more detail on the topics being covered

2. Stay updated by joining the LinkedIn community. Engage with over 800 of your peers – simply search “Antibody Drug Conjugates”

3. Check out our resource bank of exclusive reports, video interviews and speaker insights.

Something you want to share; white papers, articles or interested in speaking? Then let us know... just email any questions to info@hansonwade.com 

Get the best rates by booking now to ensure your place at this unique meeting -  Book online or call +44 (0)20 3141 8700.

World ADC Summit Advisory Board

John Lambert, Executive Vice President & Chief Scientific Officer, ImmunoGen

Paul Polakis, Director, Cancer Targets, Genentech

Hans Peter Gerber, Senior Director, Bioconjugates and Vascular Biology, Pfizer

Sanjeev Gangwar, Senior Director, Medicinal Chemistry, Bristol-Myers Squibb

Dennis Benjamin, Senior Director, Experimental Therapies, Seattle Genetics

Peter Senter, Vice President, Chemistry, Seattle Genetics

Alain Beck, Head of Physico-Chemistry Department, Pierre Fabre